US DTC Advertising Is Fastest Growing Promotional Segment

20 October 1997

Direct-to-consumer advertising of prescription medicines in the USA isthe fastest-growing promotional segment for the drug industry, according to the pharmaceutical consulting firm Scott-Levin. In its DTC Advertising 1996 report, the company noted that:

- pharmaceutical companies spent nearly $600 million in 1996 on DTC advertising of prescription drugs, up 56% from 1995;

- 10 companies accounted for more than 90% of all DTC ads in 1996, and these were Glaxo Wellcome, Johnson & Johnson, Schering-Plough, Merck & Co, Pfizer, Bristol-Myers Squibb, Wyeth Ayerst, Hoechst Marion Roussel, Bayer and SmithKline Beecham;

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight